BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 15995308)

  • 1. [The role of phosphatonin in phosphate metabolism].
    Hara S; Iida R; Yoshida H; Ohkido I; Shigematsu T
    Clin Calcium; 2005 Jul; 15(7):124-30. PubMed ID: 15995308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The phosphatonin pathway: new insights in phosphate homeostasis.
    Schiavi SC; Kumar R
    Kidney Int; 2004 Jan; 65(1):1-14. PubMed ID: 14675031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization.
    Quarles LD
    Am J Physiol Endocrinol Metab; 2003 Jul; 285(1):E1-9. PubMed ID: 12791601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FGF-23 inhibits renal tubular phosphate transport and is a PHEX substrate.
    Bowe AE; Finnegan R; Jan de Beur SM; Cho J; Levine MA; Kumar R; Schiavi SC
    Biochem Biophys Res Commun; 2001 Jun; 284(4):977-81. PubMed ID: 11409890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The phosphatonins and the regulation of phosphate transport and vitamin D metabolism.
    Sommer S; Berndt T; Craig T; Kumar R
    J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):497-503. PubMed ID: 17224271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast growth factor-23 is the phosphaturic factor in tumor-induced osteomalacia and may be phosphatonin.
    Fukumoto S; Yamashita T
    Curr Opin Nephrol Hypertens; 2002 Jul; 11(4):385-9. PubMed ID: 12105387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice.
    Sitara D; Razzaque MS; Hesse M; Yoganathan S; Taguchi T; Erben RG; Jüppner H; Lanske B
    Matrix Biol; 2004 Nov; 23(7):421-32. PubMed ID: 15579309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FGF23 and disorders of phosphate homeostasis.
    Yu X; White KE
    Cytokine Growth Factor Rev; 2005 Apr; 16(2):221-32. PubMed ID: 15863037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Genetic hypophosphatemia: recent advances in physiopathogenic concept].
    Beraud G; Perimenis P; Velayoudom FL; Wemeau JL; Vantyghem MC
    Ann Endocrinol (Paris); 2005 Apr; 66(2 Pt 1):109-16. PubMed ID: 15959411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of X-linked hypophosphatemic rickets: complications and the therapeutic use of cinacalcet.
    Raeder H; Shaw N; Netelenbos C; Bjerknes R
    Eur J Endocrinol; 2008 Dec; 159 Suppl 1():S101-5. PubMed ID: 18775977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What have we learnt about the regulation of phosphate metabolism?
    Blumsohn A
    Curr Opin Nephrol Hypertens; 2004 Jul; 13(4):397-401. PubMed ID: 15199289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibroblast growth factor 23 (FGF23) and the kidney.
    Tsagalis G; Psimenou E; Manios E; Laggouranis A
    Int J Artif Organs; 2009 Apr; 32(4):232-9. PubMed ID: 19569031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of human PHEX under the human beta-actin promoter does not fully rescue the Hyp mouse phenotype.
    Erben RG; Mayer D; Weber K; Jonsson K; Jüppner H; Lanske B
    J Bone Miner Res; 2005 Jul; 20(7):1149-60. PubMed ID: 15940367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secreted frizzled-related protein 4 is a potent tumor-derived phosphaturic agent.
    Berndt T; Craig TA; Bowe AE; Vassiliadis J; Reczek D; Finnegan R; Jan De Beur SM; Schiavi SC; Kumar R
    J Clin Invest; 2003 Sep; 112(5):785-94. PubMed ID: 12952927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphate diabetes, tubular phosphate reabsorption and phosphatonins.
    Laroche M; Boyer JF
    Joint Bone Spine; 2005 Oct; 72(5):376-81. PubMed ID: 16214071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PHEX gene and hypophosphatemia.
    Drezner MK
    Kidney Int; 2000 Jan; 57(1):9-18. PubMed ID: 10620182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-induced osteomalacia and the regulation of phosphate homeostasis.
    Kumar R
    Bone; 2000 Sep; 27(3):333-8. PubMed ID: 10962341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging role of a phosphatonin in mineral homeostasis and its derangements.
    Bielesz B
    Eur J Clin Invest; 2006 Aug; 36 Suppl 2():34-42. PubMed ID: 16884396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FGF23, hypophosphatemia, and rickets: has phosphatonin been found?
    Strewler GJ
    Proc Natl Acad Sci U S A; 2001 May; 98(11):5945-6. PubMed ID: 11371627
    [No Abstract]   [Full Text] [Related]  

  • 20. [Establishment of assay system for fibroblast growth factor (FGF)-23 and pathophysiological roles of FGF-23 in the development of hypophosphatemic diseases].
    Fukumoto S; Nakahara K
    Rinsho Byori; 2004 Jan; 52(1):51-4. PubMed ID: 14968560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.